Cancer medicines
Pomalidomide
Pomalidomide
An immunomodulatory medicine for selected previously treated myeloma.
Sources checked · Introductory guide
On this page
How it works
It affects immune responses and the tumor environment to inhibit cancer growth.[3]
Where it is used
Used in combinations for selected myeloma progressing after treatments including lenalidomide and a proteasome inhibitor.[1]
Key safety points
Strictly follow pregnancy prevention and testing. Monitor counts and clot risk; report chest pain, breathlessness, leg swelling, fever or blistering rash immediately.[2]
Questions for your care team
- How do prior responses guide this combination and clot prevention?
Sources and scope
Source documents are in English.
Entries summarize and translate linked official public sources. The source-check date records when those sources were checked; it does not indicate a clinician’s review.
- NCI · Pomalidomide (opens in a new tab)
- MedlinePlus · Pomalidomide (opens in a new tab)
- NCI Drug Dictionary · Pomalidomide (opens in a new tab)
General information based on official public sources. This is not a complete list of uses or side effects. Individual treatment decisions require your care team and current source documents. US-source uses do not establish local approval or reimbursement.